African Study Confirms Hydroxyurea's Safety and Efficacy for Children with Sickle Cell Anemia

A significant study conducted across four African sites involving 606 children and young adults with sickle cell anemia has confirmed hydroxyurea as a safe and effective standard of care. Published in The Lancet Haematology, these findings aim to reassure clinicians who have been hesitant to prescribe the drug in resource-constrained environments. This could expand access to crucial treatment.